OMX Copenhagen 20
2.020,11
PKT
-307,38
PKT
-13,21
%
Werbung
Analysen zu OMX Copenhagen 20-Werten
Datum | Rating | Analyst | |
---|---|---|---|
04.07.24 | Novo Nordisk Buy | Deutsche Bank AG | |
03.07.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
03.07.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
02.07.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
01.07.24 | A.P. Moeller - Maersk A-S (B) Underperform | Bernstein Research | |
28.06.24 | Novo Nordisk Neutral | UBS AG | |
27.06.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
27.06.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
25.06.24 | Novo Nordisk Buy | Deutsche Bank AG | |
24.06.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
24.06.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
20.06.24 | Novo Nordisk Buy | Deutsche Bank AG | |
14.06.24 | Novo Nordisk Buy | Deutsche Bank AG | |
30.05.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
28.05.24 | Novo Nordisk Buy | Deutsche Bank AG | |
24.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
15.05.24 | Novo Nordisk Neutral | UBS AG | |
14.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
14.05.24 | Novo Nordisk Neutral | UBS AG | |
08.05.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
07.05.24 | Novo Nordisk Overweight | Barclays Capital | |
06.05.24 | Novo Nordisk Neutral | UBS AG | |
03.05.24 | Novo Nordisk Halten | DZ BANK | |
03.05.24 | Novo Nordisk Buy | Deutsche Bank AG | |
03.05.24 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
03.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
02.05.24 | Novo Nordisk Overweight | Barclays Capital | |
02.05.24 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
02.05.24 | Novo Nordisk Neutral | UBS AG | |
02.05.24 | A.P. Moeller - Maersk A-S (B) Buy | UBS AG | |
02.05.24 | A.P. Moeller - Maersk A-S (B) Underperform | Bernstein Research | |
02.05.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
02.05.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
03.04.24 | A.P. Moeller - Maersk A-S (B) Buy | UBS AG | |
15.12.23 | A.P. Moeller - Maersk A-S (B) Overweight | JP Morgan Chase & Co. | |
13.12.23 | A.P. Moeller - Maersk A-S (B) Overweight | JP Morgan Chase & Co. | |
08.11.23 | A.P. Moeller - Maersk A-S (B) Overweight | JP Morgan Chase & Co. | |
03.11.23 | A.P. Moeller - Maersk A-S (B) Buy | UBS AG | |
03.11.23 | A.P. Moeller - Maersk A-S (B) Sell | Goldman Sachs Group Inc. | |
03.11.23 | A.P. Moeller - Maersk A-S (B) Neutral | JP Morgan Chase & Co. |